Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
10/23/2003 | US20030199566 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same |
10/23/2003 | US20030199552 Amide derivatives as NMDA receptor antagonists |
10/23/2003 | US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles |
10/23/2003 | US20030199531 Biodegradation-resistant mimics of pentapeptide tyrosine-isoleucine-glycine-serine-arginine (YIGSR) binding site for laminin binding protein |
10/23/2003 | US20030199520 Sulfonamide hydroxamates |
10/23/2003 | US20030199519 Prodrugs of CC-1065 analogs |
10/23/2003 | US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
10/23/2003 | US20030199499 Novel guanidinobenzamides |
10/23/2003 | US20030199497 Novel calcium receptor active molecules and method for preparing same |
10/23/2003 | US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2 |
10/23/2003 | US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
10/23/2003 | CA2481313A1 Bicyclic amides |
10/23/2003 | CA2480856A1 Substituted aryl amides |
10/23/2003 | CA2480832A1 Nitric oxide donors, compositions and methods of use |
10/23/2003 | CA2480759A1 Improved prodrugs of cc-1065 analogs |
10/22/2003 | EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon |
10/22/2003 | EP1354876A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril |
10/22/2003 | EP1354875A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril |
10/22/2003 | EP1354874A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril |
10/22/2003 | EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it |
10/22/2003 | EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes |
10/22/2003 | EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
10/22/2003 | EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
10/22/2003 | EP1353898A2 Compounds to treat alzheimer's disease |
10/22/2003 | EP1353890A1 Obtaining anthracene and carbazole by melt-crystallization |
10/22/2003 | EP1353673A1 Camptothecin derivatives |
10/22/2003 | EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
10/22/2003 | EP1097136B1 Process for the preparation of an indole derivative |
10/22/2003 | CN1451014A Peptidomimetic protease inhibitors |
10/22/2003 | CN1450991A Hydroxamate derives useful as deacetylase inhibitors |
10/22/2003 | CN1450896A Use of indole derivatives for intracular pressure for reducing |
10/22/2003 | CN1450893A Method for treatment of sepsis |
10/22/2003 | CN1450049A N-arylating method using amino-acid as additives |
10/22/2003 | CN1125071C Phthalocyanine and use of phthalocyanine as marking agent |
10/22/2003 | CN1125047C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole process for its preparation and pharmaceutical use |
10/22/2003 | CN1125040C Therapeutic compound-fatty acid conjugates |
10/21/2003 | US6635771 N-benzhydryl indole compounds |
10/21/2003 | US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain |
10/21/2003 | US6635670 Such as N-(2-((3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4 -yl)oxy)acetyl)glycine; inflammatory diseases |
10/21/2003 | US6635669 Kinase inhibitor; benign prostatic hyperplasia |
10/21/2003 | US6635668 Imidazoline receptor binding compounds |
10/21/2003 | US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors |
10/21/2003 | US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders |
10/21/2003 | US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment |
10/21/2003 | US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine |
10/21/2003 | CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
10/21/2003 | CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
10/21/2003 | CA2037100C 6-substituted-hexahydrobenz ¢cd! indoles |
10/16/2003 | WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
10/16/2003 | WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same |
10/16/2003 | WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
10/16/2003 | WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same |
10/16/2003 | WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation |
10/16/2003 | WO2003084915A1 Novel thyroid receptor ligands |
10/16/2003 | WO2003053922A3 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
10/16/2003 | WO2003027314A3 Protected linker compounds |
10/16/2003 | US20030195365 CC-1065 analog synthesis |
10/16/2003 | US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
10/16/2003 | US20030195360 For therapy of oncoses |
10/16/2003 | US20030195355 Indole-type derivatives as inhibitors of p38 kinase |
10/16/2003 | US20030195258 Taxol enhancer compounds |
10/16/2003 | US20030195244 Nitrogen compounds such as (6-Methoxy-1H-indol-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone, administered for prophylaxis of cancer; angiogenesis inhibitors |
10/16/2003 | US20030195238 Enzyme inhibitors |
10/16/2003 | US20030195234 Substituted oxindole derivatives as tyrosine kinase inhibitors |
10/16/2003 | US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents |
10/16/2003 | US20030195223 Antithrombotic agents |
10/16/2003 | US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones |
10/16/2003 | US20030195208 Phthalimido derivatives and a process for their preparation |
10/16/2003 | US20030195201 Vanilloid receptor ligands and their use in treatments |
10/16/2003 | US20030195187 For therapy of obesity or type II diabetes |
10/16/2003 | US20030195159 HIV protease inhibitors based on amino acid derivatives |
10/16/2003 | US20030194740 System and method for nucleic acid sequencing by polymerase synthesis |
10/16/2003 | CA2481976A1 Novel thyroid receptor ligands |
10/16/2003 | CA2481888A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
10/16/2003 | CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same |
10/15/2003 | EP1352650A1 Inhibitors against the production and release of inflammatory cytokines |
10/15/2003 | EP1351946A2 Materials and methods to potentiate cancer treatment |
10/15/2003 | EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor |
10/15/2003 | EP1351924A2 Diamines as modulators of chemokine receptor activity |
10/15/2003 | EP1228041B1 Indole derivatives and their use as 5ht2a ligands |
10/15/2003 | EP1051374B1 The use of compressed carbon dioxide in chemical reactions |
10/15/2003 | EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
10/15/2003 | EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use |
10/15/2003 | CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
10/15/2003 | CN1449287A Fused pyrrolocarbazoles against inflammation |
10/15/2003 | CN1449286A Carvedilol |
10/15/2003 | CN1124265C Method for producing aromatic bisimides |
10/15/2003 | CN1124262C Indole derivatives useful as endothelin receptor antagonists |
10/14/2003 | US6632962 Caspase inhibitors and uses thereof |
10/14/2003 | US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like |
10/14/2003 | US6632834 Compositions and methods for treating conditions responsive to estrogen |
10/14/2003 | US6632830 ACE-2 inhibiting compounds and methods of use thereof |
10/14/2003 | US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives |
10/14/2003 | US6632810 Cyclic diamine compound with condensed-ring groups |
10/09/2003 | WO2003083063A2 Common ligand mimics: naphtoates |
10/09/2003 | WO2003082928A1 Control agents for living-type free radical polymerization and methods of polymerizing |
10/09/2003 | WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
10/09/2003 | WO2003082860A1 Processes for producing indole compound |
10/09/2003 | WO2003082853A1 New compounds |
10/09/2003 | WO2003082835A1 Process for the preparation of morpholine derivatives and intermediates therefore |